Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus.
Based on the life-time cost to the health care system, the Institute of Medicine has assigned the highest priority for a vaccine to control human cytomegalovirus (HCMV) disease in transplant patients and new born babies. In spite of numerous attempts successful licensure of a HCMV vaccine formulatio...
Main Authors: | Jie Zhong, Michael Rist, Leanne Cooper, Corey Smith, Rajiv Khanna |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-09-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18806877/?tool=EBI |
Similar Items
-
Immune Response Induced by Immunisation with Antiviral Vaccines
by: N. A. Alpatova, et al.
Published: (2020-03-01) -
Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian National Immunisation Program
by: Eliane Matos dos Santos, et al.
Published: (2014-06-01) -
Adolescent immunisation in Africa in the decade of vaccines
by: Abdullahi, Leila Hussein
Published: (2019) -
Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines--exploratory analyses within a randomised controlled trial.
by: Ameneh Khatami, et al.
Published: (2014-01-01) -
Conditions for sustainability in the Global Alliance for Vaccines and Immunisation
by: Murphy, Catherine Estelle
Published: (2005)